1.4499
0.1199 (9.02%)
0.1199 (9.02%)
Upgrade to Real-Time
Afterhours (Closed)
Volume | 121,755 |
|
|||||
News | - | ||||||
Day High | 1.3865 | Low High |
|||||
Day Low | 1.305 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Clearside Biomedical Inc | CLSD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.33 | 1.305 | 1.3865 | 1.33 | 1.33 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
549 | 121,755 | $ 1.34 | $ 163,164 | - | 0.98 - 2.85 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:58:45 | 4 | $ 1.33 | USD |
Clearside Biomedical Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 87.27M | 60.19M | 54.48M | $ 29.58M | $ -7.74M | 0.01 | -24.20 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | -1.39M | 9.10% |
Clearside Biomedical News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLSD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.48 | 1.5898 | 1.2825 | 1.40 | 110,505 | -0.0301 | -2.03% |
1 Month | 1.09 | 1.82 | 1.07 | 1.47 | 248,706 | 0.3599 | 33.02% |
3 Months | 1.46 | 1.82 | 0.98 | 1.28 | 294,936 | -0.0101 | -0.69% |
6 Months | 1.63 | 1.83 | 0.98 | 1.31 | 200,895 | -0.1801 | -11.05% |
1 Year | 1.85 | 2.85 | 0.98 | 1.77 | 402,489 | -0.4001 | -21.63% |
3 Years | 2.75 | 7.73 | 0.98 | 3.44 | 676,516 | -1.30 | -47.28% |
5 Years | 6.42 | 15.329 | 0.56 | 3.67 | 697,626 | -4.97 | -77.42% |
Clearside Biomedical Description
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. |